This episode is all about the risk and reward of decision-making. Sometimes we avoid making decisions, and often we never learn from our bad ones. I was fortunate that I became a high-frequency currency trader 20 years ago and learned how to make lots of decisions every hour that I could never regret, and only learn from. But that doesn’t mean I don't still fall prey to the bad habits we all have when faced with uncertainty and risk.Please pick a time stamped topic below:
(0:20) – Risk-Reward Analysis for Better Decision-Making
(2:40) - The 6 Pillars of Great Trader Behavior
(6:00) - Behavioral Finance and Neural Science: Your Brain Isn't Meant To Trade
(11:00) - Peter Diamandis and Steven Kotler's Book, Abundance
(19:30) - Biotech Stocks: Gilead Buys Kite Pharma
(24:30) - Why Kevin Sold JUNO While Its Still On The Rise
(32:00) - Episode Roundup: Podcast@Zacks.com
While "the biotech century" cures cancer, it's also tackling dozens of neurological diseases investors should learn about. Please pick a time stamped topic below:
(1:00) - Neuroscience: The 4 Theaters Of The Brain
(5:00) - Investors Train Their Brains to Trade: Assumption and Perception
(10:00) - Neurology Is The New Oncology: The Boom In Brain Sciences
(14:00) - Biotech Companies With Breakthrough Research
(21:00) - Appreciating Differences: The Story Of A Misdiagnosis
(34:00) - Episode Roundup: Podcast@Zacks.com
One analyst predicts AR/VR markets to grow to $100 billion in 4 years and diagrams 4 hardware + software waves Apple owns. Please pick a time stamped topic below:
(1:00) - Facebook Hires Regina Dugan: Former DARPA Engineer
(5:30) - Tim Merel of Digi-Capital: AR & VR Expert
(8:45) - Pokémon GO's Success
(11:45) - 5 Big Challenges for AR
(16:30) - Tim Merel's Four Waves of AR
(18:45) - Why Apple Will Own AR
(23:30) - Alibaba: The Amazon of China
(27:00) - Episode Roundup: Podcast@Zacks.com